VAERS reports by lot

GSK Varicella/Shingles lot X3M27: VAERS reports

44 VAERS reports list lot X3M27 as a GSK Varicella/Shingles vaccine, received between 2018-02-22 and 2020-04-27. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
44
Reports
7%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction5427%
General / Systemic (non-local)5025%
Dermatological (non-injection-site)2915%
Musculoskeletal189%
Allergic / Anaphylactic168%
Neurological116%
Cardiac / Cardiovascular74%
Gastrointestinal63%
Thrombotic / Hematological21%
Respiratory21%
Psychiatric / Neuropsychiatric21%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas4
New York4
South Carolina3
Ohio3
Tennessee2
Massachusetts2
Washington2
Missouri2
Minnesota2
Virginia2
Florida2
California1

Reports by month received

2018-021
2018-034
2018-0411
2018-0510
2018-065
2018-074
2018-084
2018-091
2018-101
2019-061
2020-042

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.